LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Confirmation Required for Negative Rapid Group A Streptococcal Test

By LabMedica International staff writers
Posted on 11 Jun 2014
Image: Scanning electron micrograph of Streptococcus pyogenes, the bacteria associated with Group A streptococcal pharyngitis (Photo courtesy of S. Lowry).
Image: Scanning electron micrograph of Streptococcus pyogenes, the bacteria associated with Group A streptococcal pharyngitis (Photo courtesy of S. Lowry).
Negative tests results from a rapid analysis of a throat swab for Group A streptococcal (GAS) pharyngitis, performed in a doctor's office should be confirmed through a follow-up laboratory culture.

Clinical guidelines state that negative rapid antigen detection tests (RADTs) for GAS do not require confirmation by a back-up method in adults, whereas laboratory-based guidelines mandate confirmation of a negative RADT in patients of all ages.

Scientists at the University of Washington Medical Center (Seattle, WA, USA) carried out a retrospective analysis of 726 patients, aged 13 and older, with negative RADTs and positive GAS throat cultures performed between January 1, 2000 and Dec 31, 2011, at two academic medical centers in Seattle. Complication rates, treatment, modified Centor score and bacterial burden in patients with negative RADTs and positive GAS throat cultures were assessed.

Modified Centor scores greater than or equal to 2 were observed in 55% of patients with a negative RADT and positive GAS culture. Of these, 77% of patients had a moderate or heavy bacterial burden, equal to or greater than 2+. RADTs failed to detect some patients who presented with serious complications of GAS pharyngitis as 29 (4.0%) had peritonsillar abscesses and two (0.28%) were diagnosed with acute rheumatic fever.

The investigators found culture results to be useful for initiating antibiotic therapy or confirming a clinical diagnosis. Antibiotic treatment was prescribed in 68.7% of patients, with culture-directed initiation of therapy documented in 43.5%. The scientists found that more than 1,000 patients whose rapid throat cultures were negative actually turned out to have Group A Streptococcus in their laboratory throat cultures. Streptococcus pyogenes, was the bacteria associated with Group A streptococcal pharyngitis.

The authors concluded that appropriate use of rapid and culture-based diagnostic tests can reduce inappropriate use of antibiotics for sore throats, while avoiding under-treatment of patients who can benefit from antibiotics. Ferric C. Fang, MD, professor of microbiology and laboratory medicine and senior author of the study said, “Each year nearly seven million Americans seek medical attention for a sore throat, making it one of the most common reasons to see a doctor.” The study was published on May 27, 2014, in the journal Clinical Infectious Diseases.

Related Links:

University of Washington Medical Center


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more